Journal Home
Search for

Volume 88, Issue 3, Pages 295-297 (March 2007)


View previous. 7 of 37 View next.

Motor Points for the Neuromuscular Blockade of the Subscapularis Muscle

Presented in part to the Seddon Society, June 16, 2006, Stanmore, UK, and the British Association of Clinical Anatomists, July 18, 2006, Keele, Staffordshire, UK.

Tim P. Harrison, MBBS, BSca, Anna Sadnicka, MBChB, BSca, Deborah M. Eastwood, MB, FRCSbCorresponding Author Informationemail address

Abstract 

Harrison TP, Sadnicka A, Eastwood DM. Motor points for the neuromuscular blockade of the subscapularis muscle.

Objective

To locate the motor points of the subscapularis muscle in relation to palpable anatomic landmarks and hence suggest a technique for botulinum toxin injection into subscapularis applicable to patients of all ages.

Design

Anatomic dissection of the innervation of 20 subscapular muscles.

Setting

University dissecting room.

Cadavers

Ten formalin-preserved cadavers.

Interventions

Not applicable.

Main Outcome Measure

The location of motor points in relation to anatomic landmarks.

Results

The median number of motor points for the subscapularis was 5 (range, 3−6). All motor point measurements were related to surface points and converted into proportional values along reference lines. Motor points from the 20 dissections showed clustering in a band. A line of best fit was calculated (y=1.48x–0.743).

Conclusions

We describe an injection technique that would deliver botulinum toxin close to the motor points of the subscapularis, a surrogate marker of the motor endplate zones. By using proportional distances, this technique is applicable to an adult and pediatric population. This should lead to an increased efficacy and decreased side-effect profile in clinical practice, although clinical trials will need to confirm this.

Article Outline

Abstract

Methods

Results

Discussion

Conclusions

Acknowledgment

References

Copyright

UPPER-LIMB SPASTICITY IS A disabling feature of neurologic conditions such as cerebral palsy and stroke. Spasticity of the subscapularis (along with the other internal rotators) overwhelms the relative weakness of the rest of the rotator cuff resulting in internal rotation and adduction of the arm with associated pain.1

Focal neuronal or neuromuscular blockade has been shown to be effective in the treatment of upper-limb spasticity, relieving pain and improving the range of movement.1, 2, 3, 4 Botulinum toxin injection is currently the most popular method employed for achieving this. The toxin blocks transmission at the neuromuscular junction leading to weakness by chemodenervation.5 Many authors believe that maximal efficacy of botulinum toxin is achieved by injecting the toxin as close as possible to its effector site, the motor endplate.6, 7, 8, 9, 10

Currently, there is little formal advice on how to inject botulinum toxin into the subscapularis muscle. In general, the simplest method suggested for localizing the site to inject botulinum toxin is palpation of the muscle belly but this is essentially impossible for the subscapularis muscle because of its location. Many clinicians have relied on books such as the Anatomical Guide for the Electromyographer,11 which gives advice on the optimal site of insertion of electrodes for the neurophysiologic study of muscles, to help identify sites for botulinum toxin injection. In this book, there is no mention of the subscapularis muscle. Nerve stimulation and/or formal electromyography to localize the muscle, the motor points, or the motor endplates is also limited in patients with spasticity and dystonias because they are unable to tolerate the procedure without sedation or anesthesia. To identify endplate potentials, the patient must be able to maintain their muscles in a relaxed state.

Motor endplates have been shown to cluster around motor points (the macroscopic entry point of a nerve into a muscle).9, 12, 13 Therefore, the localization of motor points provides a surrogate marker of the endplate zone and hence the site of injection.

This study investigates the anatomic location of motor points in the subscapularis muscle in relation to surface anatomy landmarks to enable us to suggest a technique for injecting the subscapularis that would be appropriate for use in both children and adults.

Methods 

return to Article Outline

Twenty subscapular muscles were dissected from 10 cadaveric bodies. The material was obtained under the UK Anatomy Act of 1984. The muscles were skeletally mature and preserved with embalming fluid (methylated spirit, 10% phenol, glycerol, and formalin). Six cadavers were women and 4 were men. The mean age of death ± standard deviation was 74.7±5.8 years (range, 65−84y). There was no evidence of previous injury or surgical procedure around the shoulder joint. The cause of death had not involved any pathologic process that could have affected the innervation pattern of the subscapularis muscle. Cadavers were placed in the prone position, and skin and superficial fascia were removed. The latissimus dorsi and rhomboid major and minor were divided. Serratus anterior was divided at its attachment to the medial border of the scapula and reflected to reveal the subscapularis muscle. The arm was internally rotated, and the subscapular nerves were traced from their origins on the posterior cord of the brachial plexus to their macroscopic entry into the muscle (the motor point).

A metal pin was hammered through the scapula at each motor point and this dorsal position marked. The acromial tip, the medial end of the spine of the scapula, and the inferior angle of the scapula were identified. The dorsal positions of the motor points and surface anatomy positions were recorded onto a transparency overlay and then transferred directly to graph paper.

An x axis was devised such that the vertex of the inferior angle was point (0,0) and the acromial tip always lay on the x axis (fig 1). Coordinates for the medial spine and the motor points were recorded. These coordinates were translated into proportions by dividing the values by the distance along the reference line from the inferior angle of the scapula to the acromial tip. This allowed comparison between specimens. For each dissection, graphical representation of the motor points generated a line of best fit, and the equation of this line was calculated. The average of these 20 lines was then found. The mean position of the medial spine was also calculated. All calculations and graphs were made by using Excel.a


View full-size image.

Fig 1. Graphical representation of data from the 20 subscapularis dissections. The graph is shown as an overlay to a pen drawing of a scapula. The axes are thus shown with the vertex of the inferior angle as point (0,0) and the acromial tip on the x axis. All data are plotted as proportions relative to the distance between the inferior angle and the acromial tip. The motor points are displayed as a scatter plot (red diamonds), and the line of best fit is shown as a solid black line (y=1.48x–0.743). The line of best fit transects the x axis at .50. The position of the medial spines in each dissection is also shown (blue diamonds), with the mean position shown by the black diamond.


Results 

return to Article Outline

The number of motor nerve branches and hence motor points for each subscapularis muscle varied between 3 and 6 with a median value of 5. The distance between the inferior angle and the acromial tip had a mean value of 18.9cm (range, 16.2−21.1cm). The scatterplot of all of the motor points from the 20 dissections showed clustering of the motor points in a band (see fig 1). A line of best fit was calculated; this bisected the hypothetical line connecting the inferior spine and the acromial tip (x=.50). We believe that this line of best fit represents the optimal path for the injection of botulinum toxin into the subscapularis muscle (fig 2).


View full-size image.

Fig 2. Mock-up of proposed injection technique. Abbreviations: AT, acromial tip; IA, inferior angle; MS, medial spine. Legend: —, imaginary line connecting IA with AT; ---, the path of the injection needle bisects this and aims for the mid-point between the MS and AT.


Discussion 

return to Article Outline

This study has identified the anatomic motor points of the multipennate subscapularis muscle and related these in terms of proportional distances to 3 fixed bony landmarks. By using this information, we are able to suggest a method for injecting botulinum toxin close to its site of action at the endplate zone within the subscapularis muscle.

Botulinum toxin is taken up by and acts on the terminal nerve endings that form the neuromuscular junction with the motor endplate where it blocks the release of acetylcholine, thus interfering with transmission.5 Identifying motor endplate zones in large adult human muscles is difficult and involves staining cryosectioned fresh whole muscle. Although in unipennate muscles the motor endplate zones have been shown to cluster in a narrow band around the mid point of the muscle fibers, their location in multipennate muscles such as the subscapularis is less clear.14, 15, 16 Studies of the gastrocnemius complex in humans have shown that the motor endplate zone lies just distal to the motor points, the proximal limit of the motor endplate zone coinciding with the motor points.9, 13 Similarly, a study of human facial muscles12 found the motor endplate zone in the immediate vicinity of the nerves’ entrance point. This confirms current thinking that the terminal arborization of the motor nerve occurs just distal to its point of entry in the muscle. Therefore, it has been suggested that the location of the motor endplates corresponds with the location of the motor points, and hence the motor points are a good surrogate site for injection.6 It is for these reasons that we elected to identify the motor points.

Botulinum toxin has been shown to be most effective when injected close to the motor endplates.10 It is able to spread easily along the muscle length and through muscle fascia17 to produce a gradient of chemodenervation, the magnitude and extent of which depends on the dose.18 Saturation of a motor endplate zone may occur, and in such cases diffusion of the toxin may be more obvious clinically with effects at distant sites. Hence, most side effects occur when high total doses of botulinum toxin are used.19

The subscapularis is the strongest of the internal rotator muscles of the shoulder and is implicated in spastic pathology as a cause of pain and/or loss of function. The aim of this study was to discover if the motor points of the subscapularis lie in a definable region, which would provide a site for botulinum toxin injection in clinical practice.

Our dissection confirmed the variable nerve supply to the subscapularis as described by Kato.20 The superior subscapular nerve usually arises as 2 separate branches (the superior and middle subscapular branches) from the posterior divisions of the upper 2 trunks; these nerves supply the bulk of the muscle. The inferior subscapular nerve gives a branch to the axillary portion or subscapularis and then terminates in and supplies the teres major.20

Despite the variability in the origin and number of nerve branches supplying the subscapularis, our results show that the motor points lie in a constant band across the muscle. The line of best fit shows what we believe to be the optimal path along which to inject botulinum toxin into the subscapularis. Our line of best fit bisects a hypothetical line between the inferior angle of the scapula and its acromial tip; therefore, the needle should be inserted at this point. The angle of injection relative to the line is 56°. This can be achieved by directing the needle to a point approximately half way along the spine of the scapula (see fig 2). To maximize coverage of these motor points, the toxin should be injected from the lateral border of the scapula up until the level of the spine of the scapula.

This technique for injection of the motor points of the subscapularis is best achieved from a posterior axillary fold approach. Chiodo et al21 compared 3 methods for needle insertion into the subscapularis (a posterior axillary fold approach, an apical approach, and a medial/vertebral approach) and found the posterior axillary fold approach to be the most successful in terms of needle placement within the muscle and least associated risk of damaging other structures.

Motor innervation of muscles is complete in early childhood, and the localization of endplates within adult human muscle has been shown to correlate with the localization of endplates in the child’s muscles.14, 15, 16 The use of proportional distances allows the application of this method of injection to both the adult and pediatric populations affected by a variety of neuromuscular conditions. This should lead to an increased efficacy and decreased side-effect profile in clinical practice, although clinical trials will be needed to confirm this. The subscapularis is the strongest of the internal rotators. Further research is needed to define an optimal injection technique for the other internal rotator muscles of the shoulder.

Conclusions 

return to Article Outline

Identification of the motor points for the subscapularis muscle in relation to surface anatomy landmarks has allowed us to propose a method for the neuromuscular blockade of this muscle that is applicable to both children and adults alike. If injections are delivered more accurately to their site of action, we assume that they will be more clinically effective and that the risk of side effects will be reduced.

Supplier

Acknowledgments 

return to Article Outline

We thank Ian Johnson, MBChB, Stefan Sadnicki, BSc, and the staff of the University College London dissecting room.

References 

return to Article Outline

1. 1Yelnik AP, Colle FM, Bonan IV. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin A in the subscapular muscle. Eur Neurol. 2003;50:91–93. MEDLINE | CrossRef

2. 2Hecht JS. Subscapular nerve block in the painful hemiplegic shoulder. Arch Phys Med Rehabil. 1992;73:1036–1039. MEDLINE

3. 3Chironna RL, Hecht JS. Subscapularis motor point block for the painful hemiplegic shoulder. Arch Phys Med Rehabil. 1990;71:428–429. MEDLINE

4. 4van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med. 2002;34:51–61. MEDLINE | CrossRef

5. 5Davis EC, Barnes MP. Botulinum toxin and spasticity. J Neurol Neurosurg Psychiatry. 2000;69:143–147. MEDLINE | CrossRef

6. 6Childers MK. Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil. 2004;83(Suppl 1):S38–S44. MEDLINE | CrossRef

7. 7Childers MK, Kornegay JN, Aoki R, Otaviani L, Bogan DJ, Petroski G. Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model. Muscle Nerve. 1998;21:653–655. CrossRef

8. 8Crystal R, Malone AA, Eastwood DM. Motor points for neuromuscular blockade of the adductor muscle group. Clin Orthop Relat Res. 2005;(437):196–200.

9. 9Parratte B, Tatu L, Vuillier F, Diop M, Monnier G. Intramuscular distribution of nerves in the human triceps surae muscle: anatomical bases for treatment of spastic drop foot with botulinum toxin. Surg Radiol Anat. 2002;24:91–96. MEDLINE | CrossRef

10. 10Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve. 1993;16:964–969. CrossRef

11. 11Perotto AO. Anatomical guide for the electromyographer: the limbs and trunk. 3rd ed.. Springfield: CC Thomas; 1994;.

12. 12Happak W, Liu J, Burggasser G, Flowers A, Gruber H, Freilinger G. Human facial muscles: dimensions, motor endplate distribution, and presence of muscle fibers with multiple motor endplates. Anat Rec. 1997;249:276–284. CrossRef

13. 13Sook Kim H, Hye Hwang J, Lee PK, et al. Localization of the motor nerve branches and motor points of the triceps surae muscles in Korean cadavers. Am J Phys Med Rehabil. 2002;81:765–769. MEDLINE | CrossRef

14. 14Coers C. Structural organization of the motor nerve endings in mammalian muscle spindles and other striated muscle fibers. Am J Phys Med. 1959;38:166–175. MEDLINE

15. 15Christensen E. Topography of terminal motor innervation in striated muscles from stillborn infants. Am J Phys Med. 1959;38:65–78. MEDLINE

16. 16Aquilonius SM, Askmark H, Gillberg PG, Nandedkar S, Olsson Y, Stalberg E. Topographical localization of motor endplates in cryosections of whole human muscles. Muscle Nerve. 1984;7:287–293. CrossRef

17. 17Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope. 1991;101:960–964.

18. 18Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord. 1994;9:31–39. MEDLINE | CrossRef

19. 19Bakheit AM, Severa S, Cosgrove A, et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol. 2001;43:234–238. MEDLINE | CrossRef

20. 20Kato K. Innervation of the scapular muscles and its morphological significance in man. Anat Anz. 1989;168:155–168. MEDLINE

21. 21Chiodo A, Goodmurphy C, Haig A. Cadaveric study of methods for subscapularis muscle needle insertion. Am J Phys Med Rehabil. 2005;84:662–665. MEDLINE | CrossRef

a Department of Anatomy and Developmental Biology, University College London, London, UK

b Great Ormond Street Hospital, London, UK.

Corresponding Author InformationCorrespondence to Deborah M. Eastwood, MB, FRCS, Dept of Orthopaedics, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

Reprints are not available from the author.

a Microsoft Corp, One Microsoft Way, Redmond, WA 98052.

PII: S0003-9993(06)01588-7

doi:10.1016/j.apmr.2006.12.031


View previous. 7 of 37 View next.